206 related articles for article (PubMed ID: 10022520)
1. Divergent regulation of 1,25-dihydroxyvitamin D3 on human bone marrow osteoclastogenesis and myelopoiesis.
Qi DY; Perkins SL; Kling SJ; Russell RG
J Cell Biochem; 1999 Mar; 72(3):387-95. PubMed ID: 10022520
[TBL] [Abstract][Full Text] [Related]
2. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue.
Hattersley G; Chambers TJ
J Cell Physiol; 1990 Jan; 142(1):201-9. PubMed ID: 2153687
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
[TBL] [Abstract][Full Text] [Related]
4. Derivation of osteoclasts from hematopoietic colony-forming cells in culture.
Kerby JA; Hattersley G; Collins DA; Chambers TJ
J Bone Miner Res; 1992 Mar; 7(3):353-62. PubMed ID: 1585838
[TBL] [Abstract][Full Text] [Related]
5. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
[TBL] [Abstract][Full Text] [Related]
6. Relative roles of osteoclast colony-stimulating factor and macrophage colony-stimulating factor in the course of osteoclast development.
Lee TH; Fevold KL; Muguruma Y; Lottsfeldt JL; Lee MY
Exp Hematol; 1994 Jan; 22(1):66-73. PubMed ID: 8282061
[TBL] [Abstract][Full Text] [Related]
7. IL-1 inhibits B cell differentiation in long term bone marrow cultures.
Dorshkind K
J Immunol; 1988 Jul; 141(2):531-8. PubMed ID: 3260256
[TBL] [Abstract][Full Text] [Related]
8. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
Gorny G; Shaw A; Oursler MJ
Exp Cell Res; 2004 Mar; 294(1):149-58. PubMed ID: 14980510
[TBL] [Abstract][Full Text] [Related]
9. Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hormone or 1,25-dihydroxyvitamin D3.
Morohashi T; Corboz VA; Fleisch H; Cecchini MG; Felix R
J Bone Miner Res; 1994 Mar; 9(3):401-7. PubMed ID: 8191935
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 inhibits myelopoiesis but not B-lymphopoiesis in long-term bone marrow cultures.
Dorshkind K; Reichel H; Norman AW
Exp Hematol; 1989 Jun; 17(5):436-42. PubMed ID: 2785458
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1,25(OH)2D3 on normal human CFU-GM: target cells of the agent in the suppression of colony formation and induction of macrophage colonies.
Takahashi T; Suzuki A; Ichiba S; Okuno Y; Sugiyama H; Imura H; Nakamura K; Iho S; Hoshino T
Int J Hematol; 1991 Feb; 54(1):57-63. PubMed ID: 1954352
[TBL] [Abstract][Full Text] [Related]
12. IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures.
Devlin RD; Reddy SV; Savino R; Ciliberto G; Roodman GD
J Bone Miner Res; 1998 Mar; 13(3):393-9. PubMed ID: 9525339
[TBL] [Abstract][Full Text] [Related]
13. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
Lee SK; Gardner AE; Kalinowski JF; Jastrzebski SL; Lorenzo JA
Bone; 2006 May; 38(5):678-85. PubMed ID: 16309985
[TBL] [Abstract][Full Text] [Related]
14. Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factor.
Hahn T; Shulman LM; Ben-Hur H; Karov Y; Barak V; Handgretinger R; Barak Y
Exp Hematol; 1994 Feb; 22(2):114-21. PubMed ID: 8299733
[TBL] [Abstract][Full Text] [Related]
15. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
[TBL] [Abstract][Full Text] [Related]
16. Induction of surface tumor necrosis factor (TNF) expression and possible facilitation of surface TNF release from human monocytic cells by granulocyte-macrophage colony-stimulating factor or gamma interferon in combination with 1,25-dihydroxyvitamin D3.
Kelsey SM; Allen PD; Razak K; Macey MG; Newland AC
Exp Hematol; 1993 Jul; 21(7):864-9. PubMed ID: 8319779
[TBL] [Abstract][Full Text] [Related]
17. Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures.
MacDonald BR; Mundy GR; Clark S; Wang EA; Kuehl TJ; Stanley ER; Roodman GD
J Bone Miner Res; 1986 Apr; 1(2):227-33. PubMed ID: 3332553
[TBL] [Abstract][Full Text] [Related]
18. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha.
Ma T; Miyanishi K; Suen A; Epstein NJ; Tomita T; Smith RL; Goodman SB
Cytokine; 2004 May; 26(3):138-44. PubMed ID: 15135808
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of NaF-induced differentiation of HL-60 cells.
Kawase T; Oguro A; Orikasa M; Burns DM
J Bone Miner Res; 1996 Nov; 11(11):1676-87. PubMed ID: 8915775
[TBL] [Abstract][Full Text] [Related]
20. The biological roles of the third component of complement in osteoclast formation.
Sato T; Abe E; Jin CH; Hong MH; Katagiri T; Kinoshita T; Amizuka N; Ozawa H; Suda T
Endocrinology; 1993 Jul; 133(1):397-404. PubMed ID: 8319587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
